drugset / Trial / NCT04209803
N-Acetyl-Cysteine for Treatment of AGA in Men
RandomizedFactorialSingle-blindTreatment
Summary
To study the effectiveness and safety of the reactive oxygen species scavenger N-acetyl-cysteine (NAC) as a single therapy and in combination with the topically applied minoxidil for the treatment of the early-onset androgenetic alopecia in men.
Timeline
- Start
- 2018-12-01
- Primary completion
- 2020-09-02
- Completion
- 2020-10-01
Publications
- Background Kaya Erdogan H, Bulur I, Kocaturk E, Yildiz B, Saracoglu ZN, Alatas O. The role of oxidative stress in early-onset androgenetic alopecia. J Cosmet Dermatol. 2017 Dec;16(4):527-530. doi: 10.1111/jocd.12300. Epub 2016 Dec 16.
- Background Mantel A, McDonald JT, Goldsborough K, Harvey VM, Chan J. Prostaglandin D2 Uses Components of ROS Signaling to Enhance Testosterone Production in Keratinocytes. J Investig Dermatol Symp Proc. 2017 Oct;18(2):S81-S84. doi: 10.1016/j.jisp.2017.01.003.
- Background Barroso LAL, Sternberg F, Souza MNIFE, Nunes GJB. Trichotillomania: a good response to treatment with N-acetylcysteine. An Bras Dermatol. 2017 Jul-Aug;92(4):537-539. doi: 10.1590/abd1806-4841.20175435.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Minoxidil | Small molecule | 5 % | Topical |
| Comparator | N-acetylcysteine | Small molecule | 600 mg | — |